Wealth Management Associates’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Sell
845
-57
-6% -$28.8K 0.13% 138
2025
Q4
$511K Buy
902
+52
+6% +$27.7K 0.18% 101
2025
Q3
$380K Buy
850
+2
+0.2% +$960 0.13% 143
2025
Q2
$461K Hold
848
0.18% 105
2025
Q1
$420K Sell
848
-1
-0.1% -$553 0.18% 110
2024
Q4
$443K Sell
849
-137
-14% -$71.4K 0.19% 103
2024
Q3
$484K Buy
986
+56
+6% +$26.1K 0.21% 93
2024
Q2
$414K Hold
930
0.19% 100
2024
Q1
$414K Sell
930
-226
-20% -$85.4K 0.19% 100
2023
Q4
$390K Hold
1,156
0.21% 105
2023
Q3
$338K Buy
1,156
+208
+22% +$65K 0.2% 113
2023
Q2
$324K Sell
948
-251
-21% -$75.9K 0.18% 117
2023
Q1
$306K Hold
1,199
0.19% 118
2022
Q4
$318K Sell
1,199
-619
-34% -$151K 0.21% 112
2022
Q3
$341K Buy
+1,818
New +$390K 0.24% 112

Other funds holding ISRG

Wealth Management Associates's ISRG Position: Q1 2026 in Review

Wealth Management Associates reduced its Intuitive Surgical (ISRG) stake by 6.3% in Q1 2026, selling an estimated $28.8K and leaving 845 shares worth $390K. The position accounts for 0.13% of the portfolio, ranked #138.

Wealth Management Associates first reported a position in ISRG in Q3 2022 and has held it in 15 quarters since. The position peaked at $511K in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Wealth Management Associates held 845 shares of Intuitive Surgical worth $390K as of Q1 2026.
  • Wealth Management Associates sold 57 Intuitive Surgical shares in Q1 2026, an estimated $28.8K.
  • Intuitive Surgical made up 0.13% of Wealth Management Associates's portfolio in Q1 2026, its #138 holding.
  • Wealth Management Associates first reported a position in Intuitive Surgical in Q3 2022 and has held it in 15 quarters since.
  • Wealth Management Associates's Intuitive Surgical position peaked at $511K in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Wealth Management Associates's 13F filing for Q1 2026, filed 13 May 2026.